About SVISS LABSS
SVISS LABSS is a Healthcare company based in Ranipet (India). It manufactures active pharmaceutical ingredients and intermediates with contract manufacturing services. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. The company has 42 employees. Its Indian entity Sviss Labss Private Limited reported revenue of ₹31.60 Cr. SVISS LABSS offers products and services including Active Pharmaceutical Ingredients and Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing, Intermediates and Chemicals and Materials. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
SVISS LABSS specializes in manufacturing Active Pharmaceutical Ingredients and Intermediates, emphasizing quality, cost-effectiveness, and safety practices. They provide contract manufacturing services, including processes like acylation and Friedel-Crafts reactions, to ensure customer satisfaction. Based in Ranipet, Tamil Nadu, India, they maintain a competent team and infrastructure for pharmaceutical production, adhering to established standards for workplace and environmental safety.
- Headquarters Ranipet, India
- Employees 42
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website svisslabss.net
- Legal Name Sviss Labss Private Limited
- Date of Incorporation 14 Mar, 1990
- Jurisdiction Tamil Nadu, India
- Annual Revenue₹31.60 Cr
FY 2024 · +241% YoY
- Net Loss-₹99.1 Lakh
FY 2024 · -3% margin
- EBITDA₹10.7 Lakh
FY 2024 · 0% margin
- Employee Count42
Associated legal entities of SVISS LABSS
SVISS LABSS operates through Sviss Labss Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sviss Labss Private Limited CIN U24231TN1990PTC018867 | Active | 14 Mar 1990 | ₹31.6 Cr | 42 | 4 | View details |
Products & Services of SVISS LABSS
SVISS LABSS offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Intermediates.
Produces high-quality APIs for pharmaceutical drug development.
Manufactures chemical intermediates for API production processes.
Board of directors of Sviss Labss Private Limited (SVISS LABSS)
Sviss Labss Private Limited is the primary company behind SVISS LABSS. The board of Sviss Labss Private Limited currently have 4 directors; the longest-serving is Pakyala Bhaskar Rao, appointed in 1990. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pakyala Bhaskar Rao DIN 00866824 | Managing Director | 23 Mar 1990 | 36 yrs 7 mo | Sviss Labss Private Limited |
| Raj Kiran Pakyala DIN 03581628 | Director | 01 Oct 2015 | 11 yrs | Sviss Labss Private Limited |
| Narendran Logan DIN 08198635 | Director | 21 Apr 2019 | 7 yrs 6 mo | Sviss Labss Private Limited |
| Sattenapalli Venkata Subbarao DIN 09819848 | Director | 12 Dec 2022 | 3 yrs 10 mo | Sviss Labss Private Limited |
Financials of SVISS LABSS
Figures of Sviss Labss Private Limited, the primary company behind SVISS LABSS, for FY 2024. Revenue was ₹31.60 Cr (+241% year on year). Net loss was -₹99.1 Lakh (-3% margin). EBITDA was ₹10.7 Lakh (0% margin). Revenue has grown at a compounded annual rate of +27% over three years and +21% over five years.
- ₹31.60 CrRevenue · FY 2024 · +241% YoY
- -₹99.1 LakhNet loss · -3% margin
- ₹10.7 LakhEBITDA · 0% margin
- ₹50.6 LakhPaid-up capital
- 42Employees (provident fund records)
- +27%Revenue CAGR, 3 years
- +21%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sviss Labss Private Limited are on its company page.
Detailed financial statements for SVISS LABSS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to SVISS LABSS
SVISS LABSS has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of SVISS LABSS
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SVISS LABSS
SVISS LABSS is headquartered in Ranipet, India. It is registered at Ranipet, Tamil Nadu, India.
SVISS LABSS has 42 employees.
The primary company behind SVISS LABSS, Sviss Labss Private Limited, reported revenue of ₹31.60 Cr for FY 2024, up 241% year on year.
SVISS LABSS specializes in manufacturing Active Pharmaceutical Ingredients and Intermediates, emphasizing quality, cost-effectiveness, and safety practices. They provide contract manufacturing services, including processes like acylation and Friedel-Crafts reactions, to ensure customer satisfaction. Based in Ranipet, Tamil Nadu, India, they maintain a competent team and infrastructure for pharmaceutical production, adhering to established standards for workplace and environmental safety.
SVISS LABSS's top competitors include Laurus Labs, Symbiotec and SeQuent.
SVISS LABSS offers Active Pharmaceutical Ingredients and Intermediates.
SVISS LABSS operates through Sviss Labss Private Limited.
The legal entities of SVISS LABSS currently have 4 directors, including Raj Kiran Pakyala, Narendran Logan, Sattenapalli Venkata Subbarao and others.